Clinical Trial Update: Expression of Sodium-glucose Co-transporter 2 in Human Heart [NA]

View source ↗

Summary

The clinical trial examining expression of sodium-glucose co-transporter 2 in the human heart for aortic valve stenosis has been withdrawn. No further results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Aortic Valve Stenosis | NA | Status: WITHDRAWN